Validity of the Italian multiple sclerosis neuropsychological screening questionnaire
- PMID: 33651198
- DOI: 10.1007/s10072-021-05141-1
Validity of the Italian multiple sclerosis neuropsychological screening questionnaire
Erratum in
-
Correction to: Validity of the Italian multiple sclerosis neuropsychological screening questionnaire.Neurol Sci. 2021 Nov;42(11):4853. doi: 10.1007/s10072-021-05168-4. Neurol Sci. 2021. PMID: 33704600 No abstract available.
Abstract
The Multiple Sclerosis Neuropsychological Questionnaire (MSNQ) is a brief questionnaire useful for screening patients with multiple sclerosis (MS) at risk for cognitive impairment. It includes a patient self-assessment (MSNQ-p) and a section for the caregiver (informant) (MSNQ-i). This study's aim was to validate the Italian version of MSNQ and to compare MSNQ scores with Symbol Digit Modality Test (SDMT), Beck Depression Inventory (BDI), and Expanded Disability Status Scale (EDSS) score, measuring cognitive skills, mood status, and physical disability respectively. We enrolled 122 MS patients (and related caregivers) at MS center of Tor Vergata University Hospital of Rome. The final study sample consisted of 122 patients with MS (90 relapsing-remitting, 24 secondary progressive, and 8 primary progressive). Our results highlighted that MSNQ has a unidimensional factor structure. Correlational analyses found a good correlation between both versions (MSNQ-p and MSNQ-i) of the questionnaire. Both MSNQ-p and MSNQ-i were correlated with clinical variables, specifically with cognitive impairment, mood disorder, and with disability. The Italian version of MSNQ is reliable and useful as screening tool to identify MS patients at high risk of cognitive impairment.
Keywords: Cognitive impairment; Depression; MSNQ; Neuropsychology; Screening.
© 2021. Fondazione Società Italiana di Neurologia.
References
-
- Chiaravalloti ND, DeLuca J (2008) Cognitive impairment in multiple sclerosis. Lancet Neurol 7:1139–1151. https://doi.org/10.1016/S1474-4422(08)70259-X - DOI - PubMed
-
- Migliore S, Ghazaryan A, Simonelli I, Pasqualetti P, Squitieri F, Curcio G, Landi D, Palmieri MG, Moffa F, Filippi MM, Vernieri F (2017) Cognitive impairment in relapsing-remitting multiple sclerosis patients with very mild clinical disability. Behav Neurol 2017:7404289. https://doi.org/10.1155/2017/7404289 - DOI - PubMed - PMC
-
- Campbell J, Rashid W, Cercignani M, Langdon D (2017) Cognitive impairment among patients with multiple sclerosis: associations with employment and quality of life. Postgrad Med J 93:143–147. https://doi.org/10.1136/postgradmedj-2016-134071 - DOI - PubMed
-
- Magistrale G, Pisani V, Argento O, Incerti CC, Bozzali M, Cadavid D, Caltagirone C, Medori R, DeLuca J, Nocentini U (2015) Validation of the World Health Organization Disability Assessment Schedule II (WHODAS-II) in patients with multiple sclerosis. Mult Scler 21:448–456. https://doi.org/10.1177/1352458514543732 - DOI - PubMed
-
- Rao SM, Leo GJ, Ellington L, Nauertz T, Bernardin L, Unverzagt F (1991) Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology 41:692–696. https://doi.org/10.1212/wnl.41.5.692 - DOI - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
